Question 1

What is the catalog number for 7-Hydroxy-3-prenylcoumarin?

Accepted Answer

The catalog number for 7-Hydroxy-3-prenylcoumarin is LDA65426.

Question 2

What sizes are available for 7-Hydroxy-3-prenylcoumarin?

Accepted Answer

7-Hydroxy-3-prenylcoumarin is available in the following size(s): 5000 mg.

Question 3

Is 7-Hydroxy-3-prenylcoumarin in stock?

Accepted Answer

7-Hydroxy-3-prenylcoumarin is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 5

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 6

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

7-Hydroxy-3-prenylcoumarin

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Frequently Asked Questions

Explore Other Products

OR5AS1, CT (OR5AS1, Olfactory receptor 5AS1, Olfactory receptor OR11-168) (Azide free) (HRP)

OR5AS1, CT (OR5AS1, Olfactory receptor 5AS1, Olfactory receptor OR11-168) (Azide free) (HRP)

Recombinant Lachesis muta muta Gamma-phospholipase A2 inhibitor LNF2 (LMM2)

Recombinant Lachesis muta muta Gamma-phospholipase A2 inhibitor LNF2 (LMM2)

Recombinant Lachesis muta muta Gamma-phospholipase A2 inhibitor LNF2 (LMM2)

Recombinant Lachesis muta muta Gamma-phospholipase A2 inhibitor LNF2 (LMM2)